Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade
- BOND RX™ Validated
- RabMAb
- Advanced Validation
- Recombinant
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(174 Publications)
Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639) is a rabbit monoclonal antibody detecting RUNX2 in Western Blot, IP, IHC-P, ChIP. Suitable for Human, Mouse, Rat.
- Biophysical QC for unrivalled batch-batch consistency
- Over 60 publications
View Alternative Names
AML3, CBFA1, OSF2, PEBP2A, RUNX2, Runt-related transcription factor 2, Acute myeloid leukemia 3 protein, Core-binding factor subunit alpha-1, Oncogene AML-3, Osteoblast-specific transcription factor 2, Polyomavirus enhancer-binding protein 2 alpha A subunit, SL3-3 enhancer factor 1 alpha A subunit, SL3/AKV core-binding factor alpha A subunit, CBF-alpha-1, OSF-2, PEA2-alpha A, PEBP2-alpha A
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
Immunohistochemical analysis of paraffin-embedded human osteosarcoma tissue labeling RUNX2 with ab236639 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human osteosarcoma (PMID : 21731849) The section was incubated with ab236639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
- IP
Unknown
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
RUNX2 was immunoprecipitated from 0.35 mg PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate 10ug with ab236639 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab236639 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution. Lane 1 : PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate 10ug
Lane 2 : ab236639 IP in PC-3 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab236639 in PC-3 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
All lanes:
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639)
Predicted band size: 57 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
RUNX2 was immunoprecipitated from 0.35 mg Saos-2 (human osteosarcoma epithelial) whole cell lysate 10ug with ab236639 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab236639 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution. Lane 1 : Saos-2 (human osteosarcoma epithelial) whole cell lysate 10ug
Lane 2 : ab236639 IP in Saos-2 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab236639 in Saos-2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 30 seconds
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
All lanes:
Immunoprecipitation - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639)
Predicted band size: 57 kDa
false
- ChIP
Lab
ChIP - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
Legend Chromatin was prepared from Saos-2 cells according to the Abcam Dual-X-ChIP protocol. Cells were fixed with 1.5 mM EGS for 30mins and then formaldehyde for 10min.
The ChIP was performed with 25 μg of chromatin, 5 μg of ab236639 (red), or 5 μg of rabbit normal IgG ab172730 (gray) and 20 μl of Protein A/G sepharose beads. The immunoprecipitated DNA was quantified by real time PCR (Taqman approach for active and inactive loci, Sybr green approach for heterochromatic loci).
Primers and probes are commercial primers from PMCID : PMC3281617
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
Immunohistochemical analysis of paraffin-embedded rat embryo 14.5 day tissue tissue labeling RUNX2 with ab236639 at 1/2000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on the cartilage cells in the rat embryo 14.5 day tissue. The section was incubated with ab236639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab236639).
- WB
Lab
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
Western blot : Anti-RUNX2 antibody [EPR22858-106] (ab236639) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab236639 was shown to bind specifically to RUNX2. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
All lanes:
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639)
Lane 1:
Saos-2 cell lysate at 20 µg
Lane 2:
MC3T3-E1 undifferentiated cell lysate at 20 µg
Lane 3:
MC3T3-E1 7-day Osteogenic differentiation cell lysate, at 20 µg
Lane 4:
MC3T3-E1 14-day Osteogenic differentiation cell lysate at 20 µg
Lane 5:
MC3T3-E1 28-day Osteogenic differentiation cell lysate at 20 µg
Lane 6:
C2C12 cell lysate at 20 µg
Lane 7:
SH-SY5Y cell lysate at 20 µg
Lane 8:
NIH/3T3 cell lysate at 20 µg
Lane 9:
LNCaP cell lysate at 20 µg
false
- WB
Lab
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
Lysates were made freshly and used in WB test immediately to minimize protein degradation.
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19419310)
Negative control : MCF-7 and HeLa (PMID : 20591170)
Exposure time : 70 seconds
All lanes:
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639) at 1/1000 dilution
Lane 1:
PC-3 (human prostate adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
MDA-MB-231 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
Saos-2 (human osteosarcoma epithelial), whole cell lysate at 20 µg
Lane 4:
MEF (mouse embryonic fibroblast (immortalized)), whole cell lysate at 20 µg
Lane 5:
C2C12 (mouse myoblasts myoblast), whole cell lysate at 20 µg
Lane 6:
MCF7 (human breast adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 7:
HeLa (human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 60 kDa,64 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5X10^5 of positive cell line Saos-2 or low expression cell line HeLa were used along with 5µg of ab236639 [EPR22858-106]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- WB
Lab
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 19419310, 20591170)
Exposure time : 3 mintues
All lanes:
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639) at 1/1000 dilution
Lane 1:
C6 (rat glial tumor glial cell), whole cell lysate at 20 µg
Lane 2:
PC-12 (rat adrenal gland pheochromocytoma), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 60 kDa,64 kDa
false
- WB
CiteAb
Western blot - Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (AB236639)
RUNX2 western blot using anti-RUNX2 antibody [EPR22858-106] - ChIP Grade ab236639. Publication image and figure legend from Luo, Y., Xia, H., et al., 2022, Evid Based Complement Alternat Med, PubMed 35769158.
ab236639 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab236639 please see the product overview.
The changes in bone metabolism parameters and serological markers in rats after 12 weeks of JWYHD intragastric treatment are described. (a) Micro-CT was used to scan three-dimensional reconstruction images of bone trabeculae. (b) BMD. (c) BV/TV. (d) Tb.Th. (e) Tb.N. (f) Tb.Sp. (g) The translocation expression of BMP2, a key protein in the pathway, was detected by immunofluorescence. (h) The protein expression was measured by WB after culturing for 1 week. (i) BMP2 translocation percentage. (j) Weight gain of rats. (k) ELISA quantified the content of bone resorption marker β-CTX in serum. (l) ELISA quantified the content of the bone formation marker P1NP in serum. (m)-(q) The quantitative measurement of protein expression (BMP2, P-SMAD1/5/8, RUNX2, OCN, PPARγ). The data were represented by mean ± SD (n = 3), p < 0.05 were considered as significant difference : * VS. SHAM group, #VS. M group.
false
Related conjugates and formulations (9)
-
Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
660 APC
APC Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
578 PE
PE Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-RUNX2 antibody [EPR22858-106] – ChIP Grade
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade
-
Anti-RUNX2 antibody [EPR22858-106] - BSA and Azide free (Capture)
Reactivity data
Product details
What is this antibody validated in?
Anti-RUNX2 antibody [EPR22858-106] - ChIP Grade (ab236639) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), ChIP in Human, Mouse, Rat samples.
What is the molecular weight of RUNX2?
Anti-RUNX2 [EPR22858-106] - ChIP Grade (ab236639) specifically detects a band for RUNX2 (UniProt: Q13950) at a molecular weight of 57kDa.
Trusted by the scientific community
Anti-RUNX2 [EPR22858-106] - ChIP Grade (ab236639) was first used in a scientific publication in 2019 and has been cited over 60 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR22858-106] also available for your convenience: ab236639, Carrier free - ab264077, Carrier free - ab275219, PE - ab318316, APC - ab318419, Alexa Fluor® 488 - ab318522, Alexa Fluor® 647 - ab318625, Alexa Fluor® 594 - ab318728, Alexa Fluor® 555 - ab318828, Alexa Fluor® 750 - ab321481
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein orchestrates bone formation by influencing the expression of genes involved in osteoblast differentiation. RUNX2 operates as part of the larger transcriptional complex that includes other proteins that modulate its activity. It maintains bone homeostasis by regulating the expression of osteogenic markers including bone sialoprotein and osteocalcin. The ability of RUNX2 to drive osteoblast lineage commitment highlights its importance in skeletal health and development.
Pathways
RUNX2 shows significant involvement in both the Wnt signaling and TGF-beta signaling pathways. Within the Wnt signaling pathway RUNX2 interacts with beta-catenin to facilitate osteoblastogenesis and support bone matrix deposition. In the TGF-beta signaling pathway RUNX2 modulates Smad-dependent transcriptional activity important for extracellular matrix production and bone remodeling. These interactions illustrate RUNX2's central role in mediating bone development and maintenance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (174)
Recent publications for all applications. Explore the full list and refine your search
Journal of nanobiotechnology 23:649 PubMed41074120
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in bioengineering and biotechnology 13:1641476 PubMed41069411
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 35:102311 PubMed41050091
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 56: PubMed40937566
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 34:102181 PubMed40893374
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cardiovascular medicine 12:1586775 PubMed40761233
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of translational medicine 23:845 PubMed40722170
2025
Applications
Unspecified application
Species
Unspecified reactive species
BMC oral health 25:1227 PubMed40696336
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 33:102027 PubMed40677394
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of traditional and complementary medicine 15:434-445 PubMed40677544
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com